 <h1>Lurasidone Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><h2>In Summary</h2><p><b>Commonly reported side effects of lurasidone include:</b> psychomotor impairment, akathisia, basal ganglia disease, bradykinesia, cogwheel rigidity, drowsiness, hypokinesia, muscle rigidity, nausea, parkinson's disease, sedated state, tremor, altered serum glucose, and drooling. <b>Other side effects include:</b> oculogyric crisis, trismus, agitation, anxiety, dystonia, torticollis, increased serum prolactin, and weight gain.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to lurasidone: oral tablet</i></p><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Tablet)</p><p>Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Lurasidone is not approved for the treatment of patients with dementia-related psychosis. An increased risk of suicidal thoughts and behavior was found in pediatric and young adult patients taking antidepressants. Monitor for clinical worsening and emergence of suicidal thoughts and behaviors.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, lurasidone may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking lurasidone:</p><p>
<i>More common</i>
</p><ul>
<li>Absence of or decrease in body movement</li>
<li>difficulty with swallowing</li>
<li>drooling</li>
<li>inability to sit still</li>
<li>incremental or ratchet-like movement of the muscle</li>
<li>loss of balance control</li>
<li>mask-like face</li>
<li>muscle discomfort</li>
<li>muscle trembling, jerking, or stiffness</li>
<li>need to keep moving</li>
<li>restlessness</li>
<li>rigid or stiff muscles</li>
<li>shakiness in the legs, arms, hands, or feet</li>
<li>shuffling walk</li>
<li>slow movements</li>
<li>slow reflexes</li>
<li>slurred speech</li>
<li>stiffness of the arms and legs</li>
<li>tic-like (jerky) movements of the head, face, mouth, and neck</li>
<li>trembling or shaking of the hands or feet</li>
<li>twisting movements of the body</li>
<li>uncontrolled movements, especially of the face, neck, and back</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Arm, back, or jaw pain</li>
<li>blurred vision</li>
<li>burning while urinating</li>
<li>changes in patterns and rhythms of speech</li>
<li>chest pain or discomfort</li>
<li>chills</li>
<li>cold sweats</li>
<li>confusion</li>
<li>difficult or painful urination</li>
<li>difficulty opening the mouth</li>
<li>difficulty with breathing</li>
<li>dizziness</li>
<li>dizziness, faintness, or lightheadedness when getting up from a lying or sitting position</li>
<li>fast, pounding, or irregular heartbeat or pulse</li>
<li>fixed position of the eye</li>
<li>headache</li>
<li>high fever</li>
<li>inability to move the eyes</li>
<li>inability to speak</li>
<li>increased blinking or spasms of the eyelid</li>
<li>increased sweating</li>
<li>lockjaw</li>
<li>loss of bladder control</li>
<li>muscle spasm, especially of the neck and back</li>
<li>nervousness</li>
<li>pale skin</li>
<li>pounding in the ears</li>
<li>seizures</li>
<li>severe muscle stiffness</li>
<li>severe or sudden headache</li>
<li>slow or fast heartbeat</li>
<li>slurred speech</li>
<li>sticking out of the tongue</li>
<li>sweating</li>
<li>temporary blindness</li>
<li>tiredness</li>
<li>trouble with breathing, speaking, or swallowing</li>
<li>troubled breathing with exertion</li>
<li>uncontrolled twisting movements of the neck, trunk, arms, or legs</li>
<li>unusual bleeding or bruising</li>
<li>unusual facial expressions</li>
<li>unusual tiredness or weakness</li>
<li>unusually pale skin</li>
<li>weakness in the arm or leg on one side of the body, sudden and severe</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Black, tarry stools</li>
<li>bloody urine</li>
<li>breast pain or swelling</li>
<li>cough</li>
<li>dark-colored urine</li>
<li>decreased frequency or amount of urine</li>
<li>fever</li>
<li>increased thirst</li>
<li>large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs</li>
<li>loss of appetite</li>
<li>lower back or side pain</li>
<li>muscle cramp, pain, or stiffness</li>
<li>nausea</li>
<li>sore throat</li>
<li>sores, ulcers, or white spots on the lips or in the mouth</li>
<li>swelling of the face, fingers, or lower legs</li>
<li>swollen glands</li>
<li>vomiting</li>
<li>weight gain</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Decreased urine output</li>
<li>hives or welts, itching, skin rash</li>
<li>loss of consciousness</li>
<li>redness of the skin</li>
<li>swelling of the throat or tongue</li>
<li>tightness in the chest</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of lurasidone may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Anxiety</li>
<li>belching</li>
<li>drowsiness</li>
<li>dry mouth</li>
<li>heartburn</li>
<li>hyperventilation</li>
<li>indigestion</li>
<li>irritability</li>
<li>relaxed and calm feeling</li>
<li>sleepiness or unusual drowsiness</li>
<li>stomach discomfort, upset, or pain</li>
<li>trouble sleeping</li>
<li>unusually deep sleep</li>
<li>unusually long duration of sleep</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Abnormal dreams</li>
<li>back pain</li>
<li>blurred vision</li>
<li>burning feeling in the chest or stomach</li>
<li>decreased appetite</li>
<li>diarrhea</li>
<li>feeling of constant movement of self or surroundings</li>
<li>indigestion</li>
<li>sensation of spinning</li>
<li>sweating</li>
<li>tenderness in the stomach area</li>
<li>watering of mouth and drooling</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Decreased interest in sexual intercourse</li>
<li>inability to have or keep an erection</li>
<li>loss in sexual ability, desire, drive, or performance</li>
<li>unexpected or excess milk flow from the breasts</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to lurasidone: oral tablet</i></p><h3>General</h3><p>The most commonly reported adverse events included somnolence, akathisia, extrapyramidal symptoms, and nausea.<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Decreased appetite, increased appetite, increased weight</p>
<p><b>Uncommon</b> (0.1% to 1%): Hyponatremia, increase in blood sugar levels/blood glucose increased<sup>[Ref]</sup></p><p>In uncontrolled, long-term schizophrenia trials, this drug was associated with a mean increase in glucose from baseline of 1.8 mg/dL at 24 weeks, 0.8 mg/dL at 36 weeks, and 2.3 mg/dL at 52 weeks.  Similar results were observed in bipolar depression studies.  The proportion of patients with a 7% or greater increase in body weight was 4.8% (compared with 3.3% for placebo).  Pooled data from short-term trials showed a mean weight gain of 0.43 kg in treated patients (compared with -0.2 kg in placebo).<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (up to 17.4%), dyspepsia (up to 11%)</p>
<p><b>Common</b> (1% to 10%): Abdominal pain, diarrhea, dry mouth, salivary hypersecretion, stomach discomfort, upper abdominal pain, vomiting</p>
<p><b>Uncommon</b> (0.1% to 1%): Dysphagia, flatulence, gastritis</p>
<p><b>Frequency not reported</b>: Difficulty swallowing, tongue protrusion, tongue spasm, tongue swelling<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Somnolence (up to 26%), akathisia (up to 22%), extrapyramidal disorder/symptoms (up to 22%), parkinsonism (up to 17%)</p>
<p><b>Common</b> (1% to 10%): Dizziness, dyskinesia, dystonia/acute dystonia, tardive dyskinesia</p>
<p><b>Uncommon</b> (0.1% to 1%): Cerebrovascular accident/adverse reactions, dysarthria, gait disturbance, lethargy, syncope, vertigo</p>
<p><b>Rare</b> (less than 0.1%): Neuroleptic malignant syndrome, seizure</p>
<p><b>Frequency not reported</b>: Abnormal glabellar reflex, bradykinesia, cogwheel rigidity, convulsion, drooling, hyperkinesia, hypersomnia, hypersomnolence, hypokinesia, motor impairment, oromandibular dystonia, sedation, stroke, tremor<sup>[Ref]</sup></p><p>Akathisia and extrapyramidal symptoms were dose-related.<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Insomnia (up to 11%)</p>
<p><b>Common</b> (1% to 10%): Abnormal dreams, agitation, anxiety, psychomotor hyperactivity, restlessness</p>
<p><b>Uncommon</b> (0.1% to 1%): Activation of mania/hypomania, catatonia, nightmare, panic attack, sleep disorder</p>
<p><b>Rare</b> (less than 0.1%): Suicidal behavior/ideation</p>
<p><b>Frequency not reported</b>: Cognitive impairment, psychomotor retardation<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Uncommon</b> (0.1% to 1%): Anemia</p>
<p><b>Rare</b> (less than 0.1%): Eosinophilia</p>
<p><b>Frequency not reported</b>: Agranulocytosis, leukopenia, neutropenia<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypertension, tachycardia</p>
<p><b>Uncommon</b> (0.1% to 1%): Angina pectoris, atrioventricular (AV) block first degree, bradycardia, hot flush, hypotension, increased blood pressure, orthostatic hypotension</p>
<p><b>Frequency not reported</b>: Deep vein thrombosis, venous thromboembolism<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain, increased blood creatinine phosphokinase, musculoskeletal stiffness</p>
<p><b>Uncommon</b> (0.1% to 1%): Joint stiffness, myalgia, neck pain</p>
<p><b>Rare</b> (less than 0.1%): Rhabdomyolysis</p>
<p><b>Frequency not reported</b>: Muscle rigidity, muscle spasms, neck muscle spasm, torticollis, trismus<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash, pruritus</p>
<p><b>Uncommon</b> (0.1% to 1%): Hyperhidrosis</p>
<p><b>Frequency not reported</b>: , Stevens-Johnson syndrome, urticaria</p>
<p><b>Postmarketing reports</b>: Bullous dermatitis, maculopapular rash, pustular rash, severe cutaneous reactions, skin eruption, skin exfoliation<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection</p>
<p><b>Uncommon</b> (0.1% to 1%): Amenorrhea, dysmenorrhea, dysuria, erectile dysfunction</p>
<p><b>Rare</b> (less than 0.1%): Breast enlargement, breast pain, galactorrhea<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Elevated serum creatinine/increased creatinine phosphokinase</p>
<p><b>Rare</b> (less than 0.1%): Renal failure<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Uncommon</b> (0.1% to 1%): Elevated prolactin levels/blood prolactin increased</p>
<p><b>Frequency not reported</b>: Hyperprolactinemia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Uncommon</b> (0.1% to 1%): Alanine aminotransferase increased<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Common</b> (1% to 10%): Hypersensitivity</p>
<p><b>Rare</b> (less than 0.1%): Angioedema</p>
<p><b>Frequency not reported</b>: Allergic rhinitis<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Viral infection (up to 11%)</p>
<p><b>Common</b> (1% to 10%): Influenza<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Blurred vision</p>
<p><b>Frequency not reported</b>: Oculogyric crisis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue</p>
<p><b>Rare</b> (less than 0.1%): Sudden death</p>
<p><b>Frequency not reported</b>: Body temperature dysregulation, falls, neonatal drug withdrawal syndrome<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Nasopharyngitis, oropharyngeal pain, rhinitis</p>
<p><b>Frequency not reported</b>: Difficulty breathing, nasal congestion, rhinorrhea, pulmonary embolism, throat tightness, upper respiratory tract infection</p>
<p><b>Postmarketing reports</b>: Dyspnea, throat swelling<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Latuda (lurasidone)." Sunovion Pharmaceuticals Inc, Marlborough, MA. </p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>Is Latuda a mood stabilizer or an antipsychotic?</li>
<li>Can you stop taking Latuda immediately?</li>
<li>Does Latuda make you sleepy?</li>
<li>How fast does Latuda work?</li>
<li>Does Latuda cause weight gain?</li>
<li>Can Latuda be cut in half or split?</li>
<li>Is Latuda a controlled substance?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about lurasidone</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>766 Reviews</li>
<li>Drug class: atypical antipsychotics</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Lurasidone &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Latuda</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Borderline Personality Disorder</li>
<li>Bipolar Disorder</li>
<li>Schizoaffective Disorder</li>
<li>Schizophrenia</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to lurasidone: oral tablet</i></p><h3>General</h3><p>The most commonly reported adverse events included somnolence, akathisia, extrapyramidal symptoms, and nausea.<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Decreased appetite, increased appetite, increased weight</p><p><b>Uncommon</b> (0.1% to 1%): Hyponatremia, increase in blood sugar levels/blood glucose increased<sup>[Ref]</sup></p><p>In uncontrolled, long-term schizophrenia trials, this drug was associated with a mean increase in glucose from baseline of 1.8 mg/dL at 24 weeks, 0.8 mg/dL at 36 weeks, and 2.3 mg/dL at 52 weeks.  Similar results were observed in bipolar depression studies.  The proportion of patients with a 7% or greater increase in body weight was 4.8% (compared with 3.3% for placebo).  Pooled data from short-term trials showed a mean weight gain of 0.43 kg in treated patients (compared with -0.2 kg in placebo).<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (up to 17.4%), dyspepsia (up to 11%)</p><p><b>Common</b> (1% to 10%): Abdominal pain, diarrhea, dry mouth, salivary hypersecretion, stomach discomfort, upper abdominal pain, vomiting</p><p><b>Uncommon</b> (0.1% to 1%): Dysphagia, flatulence, gastritis</p><p><b>Frequency not reported</b>: Difficulty swallowing, tongue protrusion, tongue spasm, tongue swelling<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Somnolence (up to 26%), akathisia (up to 22%), extrapyramidal disorder/symptoms (up to 22%), parkinsonism (up to 17%)</p><p><b>Common</b> (1% to 10%): Dizziness, dyskinesia, dystonia/acute dystonia, tardive dyskinesia</p><p><b>Uncommon</b> (0.1% to 1%): Cerebrovascular accident/adverse reactions, dysarthria, gait disturbance, lethargy, syncope, vertigo</p><p><b>Rare</b> (less than 0.1%): Neuroleptic malignant syndrome, seizure</p><p><b>Frequency not reported</b>: Abnormal glabellar reflex, bradykinesia, cogwheel rigidity, convulsion, drooling, hyperkinesia, hypersomnia, hypersomnolence, hypokinesia, motor impairment, oromandibular dystonia, sedation, stroke, tremor<sup>[Ref]</sup></p><p>Akathisia and extrapyramidal symptoms were dose-related.<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Insomnia (up to 11%)</p><p><b>Common</b> (1% to 10%): Abnormal dreams, agitation, anxiety, psychomotor hyperactivity, restlessness</p><p><b>Uncommon</b> (0.1% to 1%): Activation of mania/hypomania, catatonia, nightmare, panic attack, sleep disorder</p><p><b>Rare</b> (less than 0.1%): Suicidal behavior/ideation</p><p><b>Frequency not reported</b>: Cognitive impairment, psychomotor retardation<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Uncommon</b> (0.1% to 1%): Anemia</p><p><b>Rare</b> (less than 0.1%): Eosinophilia</p><p><b>Frequency not reported</b>: Agranulocytosis, leukopenia, neutropenia<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypertension, tachycardia</p><p><b>Uncommon</b> (0.1% to 1%): Angina pectoris, atrioventricular (AV) block first degree, bradycardia, hot flush, hypotension, increased blood pressure, orthostatic hypotension</p><p><b>Frequency not reported</b>: Deep vein thrombosis, venous thromboembolism<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain, increased blood creatinine phosphokinase, musculoskeletal stiffness</p><p><b>Uncommon</b> (0.1% to 1%): Joint stiffness, myalgia, neck pain</p><p><b>Rare</b> (less than 0.1%): Rhabdomyolysis</p><p><b>Frequency not reported</b>: Muscle rigidity, muscle spasms, neck muscle spasm, torticollis, trismus<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash, pruritus</p><p><b>Uncommon</b> (0.1% to 1%): Hyperhidrosis</p><p><b>Frequency not reported</b>: , Stevens-Johnson syndrome, urticaria</p><p><b>Postmarketing reports</b>: Bullous dermatitis, maculopapular rash, pustular rash, severe cutaneous reactions, skin eruption, skin exfoliation<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection</p><p><b>Uncommon</b> (0.1% to 1%): Amenorrhea, dysmenorrhea, dysuria, erectile dysfunction</p><p><b>Rare</b> (less than 0.1%): Breast enlargement, breast pain, galactorrhea<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Elevated serum creatinine/increased creatinine phosphokinase</p><p><b>Rare</b> (less than 0.1%): Renal failure<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Uncommon</b> (0.1% to 1%): Elevated prolactin levels/blood prolactin increased</p><p><b>Frequency not reported</b>: Hyperprolactinemia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Uncommon</b> (0.1% to 1%): Alanine aminotransferase increased<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Common</b> (1% to 10%): Hypersensitivity</p><p><b>Rare</b> (less than 0.1%): Angioedema</p><p><b>Frequency not reported</b>: Allergic rhinitis<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Viral infection (up to 11%)</p><p><b>Common</b> (1% to 10%): Influenza<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Blurred vision</p><p><b>Frequency not reported</b>: Oculogyric crisis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue</p><p><b>Rare</b> (less than 0.1%): Sudden death</p><p><b>Frequency not reported</b>: Body temperature dysregulation, falls, neonatal drug withdrawal syndrome<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Nasopharyngitis, oropharyngeal pain, rhinitis</p><p><b>Frequency not reported</b>: Difficulty breathing, nasal congestion, rhinorrhea, pulmonary embolism, throat tightness, upper respiratory tract infection</p><p><b>Postmarketing reports</b>: Dyspnea, throat swelling<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Latuda (lurasidone)." Sunovion Pharmaceuticals Inc, Marlborough, MA. </p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>Is Latuda a mood stabilizer or an antipsychotic?</li>
<li>Can you stop taking Latuda immediately?</li>
<li>Does Latuda make you sleepy?</li>
<li>How fast does Latuda work?</li>
<li>Does Latuda cause weight gain?</li>
<li>Can Latuda be cut in half or split?</li>
<li>Is Latuda a controlled substance?</li>
</ul><h2>More about lurasidone</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>766 Reviews</li>
<li>Drug class: atypical antipsychotics</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Lurasidone &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Borderline Personality Disorder</li>
<li>Bipolar Disorder</li>
<li>Schizoaffective Disorder</li>
<li>Schizophrenia</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>